论文部分内容阅读
研究显示血清前清蛋白(PA)在部分恶性肿瘤中均有不同程度的降低,提示血清PA可能成为恶性肿瘤新的诊断治疗参考指标。本研究对慢性粒细胞白血病患者的血清PA进行检测,了解和探讨血清PA作为慢性粒细胞白血病肿瘤标记的意义。1资料与方法 1.1一般资料收集遵义医学院附属医院血液科慢性粒细胞白血病慢性期(CML-CP)住院患者47例,其中男26例,女21例,年龄15~70岁;随访病例,其中34例患者最终急变,男20
Studies have shown that serum prealbumin (PA) in some malignant tumors were reduced to varying degrees, suggesting that serum PA may become a new diagnostic and therapeutic reference for malignant tumors. This study of patients with chronic myeloid leukemia serum PA detection, to understand and explore serum PA as a marker of chronic myelogenous leukemia significance. 1 Materials and Methods 1.1 General Information Collection Zunyi Medical College Hospital hematology chronic myeloid leukemia chronic phase (CML-CP) 47 cases of hospitalized patients, including 26 males and 21 females, aged 15 to 70 years; follow-up cases, including 34 patients eventually emerge suddenly, male 20